CORC  > 武汉大学
Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer
Cheng, Songtao; Wang, Gang; Wang, Yejinpeng; Cai, Liwei; Qin, Kaiyu; Ju, Lingao; Liu, Xuefeng; Xiao, Yu; Wang, Xinghuan
刊名CLINICAL SCIENCE
2019
卷号133期号:15
ISSN号0143-5221
DOI10.1042/CS20190587
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4263174
专题武汉大学
推荐引用方式
GB/T 7714
Cheng, Songtao,Wang, Gang,Wang, Yejinpeng,et al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer[J]. CLINICAL SCIENCE,2019,133(15).
APA Cheng, Songtao.,Wang, Gang.,Wang, Yejinpeng.,Cai, Liwei.,Qin, Kaiyu.,...&Wang, Xinghuan.(2019).Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer.CLINICAL SCIENCE,133(15).
MLA Cheng, Songtao,et al."Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR gamma-mediated pathway in bladder cancer".CLINICAL SCIENCE 133.15(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace